Skip to main content

Advertisement

SpringerLink
Log in

Patients’ perspectives on participation in clinical trials and subsequent ethical challenges in a hospital setting in Jordan

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The number of global clinical trials is increasing. Recruitment rate in clinical trials is a challenging task that affects sample size, power of the study, and adequate representation of the targeted population. An understanding of the worries and reasons why patients may refrain from participation in trials may lead to improved enrollment rates. Objectives To assess the rate of patients who are willing to participate in clinical trials, and aspects that might have an impact on the patients’ willingness to participate. Setting Government tertiary hospital in Jordan. Methods This is a cross-sectional study. Patients were interviewed by pharmacists in different clinics in a tertiary hospital and information was collected using a data collection sheet. Main outcome measure Factors that might predict the inclination of a patient to participate in clinical trials, and the rate of willingness to participation in randomized controlled trials in cancer patients compared to non-cancer patients. Results A total of 1193 participants were enrolled in the study, one hundred and thirty-five participants (11.3%) had cancer and 80% of the participants had at least one chronic medical condition. Majority of patients (n = 882, 73.9%) believed that trials were safe and 1106 (92.7%) patients thought they were important. Age, education level, income, having cancer or any chronic medical condition, and degree of control of chronic diseases were statistically significant predictors of the willingness of patients to participate in trials. Patients with cancer had a higher rate of acceptance to participation in randomized controlled trials compared to non-cancer patients, 80.0% versus 62.4%, p value < 0.001. Conclusion In general, almost two-thirds of patients were willing to participate in clinical trials, with a higher rate in cancer patients. Factors such as education level, income, and extent of control of medical conditions that might refrain patients from enrollment in trials will lower recruitment rate and must be addressed and taken into consideration before launching clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomized controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7:9.

    Article  Google Scholar 

  2. Nayak BK. Understanding the relevance of sample size calculation. Indian J Ophthalmol. 2010;58(6):469–70.

    Article  Google Scholar 

  3. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272(2):122–4.

    Article  CAS  Google Scholar 

  4. Charlson ME, Horwitz RI. Applying results of randomised trials to clinical practice: impact of losses before randomisation. BMJ Clin Res Ed. 1984;289(6454):1281–4.

    Article  CAS  Google Scholar 

  5. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1987;8(4 Suppl):6s–30s.

    Article  CAS  Google Scholar 

  6. Madsen SM, Mirza MR, Holm S, Hilsted KL, Kampmann K, Riis P. Attitudes towards clinical research amongst participants and nonparticipants. J Intern Med. 2002;251(2):156–68.

    Article  CAS  Google Scholar 

  7. Sood A, Prasad K, Chhatwani L, Shinozaki E, Cha SS, Loehrer LL, et al. Patients’ attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clin Proc. 2009;84(3):243–7.

    Article  Google Scholar 

  8. Al-Dakhil LO, Alanazy R, Al-Hamed RE, Al-Mandeel H, Alobaid A. Attitudes of patients in developing countries toward participating in clinical trials: a survey of Saudi patients attending primary health care services. Oman Med J. 2016;31(4):284–9.

    Article  Google Scholar 

  9. Goodare H, Lockwood S. Involving patients in clinical research. Improves the quality of research. BMJ. 1999;319(7212):724–5.

    Article  CAS  Google Scholar 

  10. Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14(1):89.

    Article  Google Scholar 

  11. Fallowfield LJ, Jenkins V, Brennan C, Sawtell M, Moynihan C, Souhami RL. Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer Oxf Engl. 1998;34(10):1554–9.

    Article  CAS  Google Scholar 

  12. McCann SK, Campbell MK, Entwistle VA. Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials. 2010;11(1):31.

    Article  Google Scholar 

  13. Moorcraft SY, Marriott C, Peckitt C, Cunningham D, Chau I, Starling N, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 2016;17:17.

    Article  CAS  Google Scholar 

  14. Lee SJ, Park LC, Lee J, Kim S, Choi MK, Hong JY, et al. Unique perception of clinical trials by Korean cancer patients. BMC Cancer. 2012;12:594.

    Article  Google Scholar 

  15. Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol. 2000;11(8):939–45.

    Article  CAS  Google Scholar 

  16. Bosnjak Pasic M, Vidrih B, Sarac H, Pasic H, Vujevic L, Soldo Koruga A, et al. Clinical trials in developing countries—ethical considerations. Psychiatr Danub. 2018;30(3):285–91.

    Article  Google Scholar 

  17. Al-Tannir MA, El-Bakri N, Abu-Shaheen AK. Knowledge, attitudes and perceptions of Saudis towards participating in clinical trials. PLoS ONE. 2016;11(2):e0143893.

    Article  CAS  Google Scholar 

  18. Al-Lawati H, Al-Baimani K, Al-Zadjali M, Al-Obaidani N, Al-Kiyumi Z, Al-Khabori MK. Knowledge and attitudes towards clinical trial participation in Oman: a cross-sectional study. Sultan Qaboos Univ Med J. 2018;18(1):e54–60.

    Article  Google Scholar 

  19. Kadam RA, Borde SU, Madas SA, Salvi SS, Limaye SS. Challenges in recruitment and retention of clinical trial subjects. Perspect Clin Res. 2016;7(3):137–43.

    Article  Google Scholar 

  20. Rajadhyaksha V. Conducting feasibilities in clinical trials: an investment to ensure a good study. Perspect Clin Res. 2010;1(3):106–9.

    PubMed  PubMed Central  Google Scholar 

  21. Nair SC, Ibrahim H, Celentano DD. Clinical trials in the Middle East and North Africa (MENA) Region: grandstanding or grandeur? Contemp Clin Trials. 2013;36(2):704–10.

    Article  Google Scholar 

  22. Woodsong C, Macqueen K, Namey E, Sahay S, Morar N, Mlingo M, et al. Women’s autonomy and informed consent in microbicides clinical trials. J Empir Res Hum Res Ethics. 2006;1(3):11–26.

    Article  Google Scholar 

  23. DasMahapatra P, Raja P, Gilbert J, Wicks P. Clinical trials from the patient perspective: survey in an online patient community. BMC Health Serv Res. 2017;17(1):166.

    Article  Google Scholar 

  24. Largent EA, Lynch HF. Paying research participants: the outsized influence of “Undue Influence”. IRB. 2017;39(4):1–9.

    PubMed  PubMed Central  Google Scholar 

  25. Unger JM, Gralow JR, Albain KS, Ramsey SD, Hershman DL. Patient income level and cancer clinical trial participation: a prospective survey study. JAMA Oncol. 2016;2(1):137–9.

    Article  Google Scholar 

  26. Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, et al. The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer. 2010;103(12):1801–7.

    Article  CAS  Google Scholar 

  27. Igwe E, Woodburn J, Davolos J, Shollenberger C, Miller SM, Hernandez E, et al. Patient perceptions and willingness to participate in clinical trials. Gynecol Oncol. 2016;142(3):520–4.

    Article  Google Scholar 

  28. National Institutes of Health Revitalization Act of 1993. Subtitle B—clinical research equity regarding women and minorities. https://orwh.od.nih.gov/sites/orwh/files/docs/NIH-Revitalization-Act-1993.pdf. Accessed 16 Nov 2019.

  29. Feldman S, Ammar W, Lo K, Trepman E, van Zuylen M, Etzioni O. Quantifying sex bias in clinical studies at scale with automated data extraction. JAMA Netw Open. 2019;2(7):e196700.

    Article  Google Scholar 

  30. Wallach JD, Sullivan PG, Trepanowski JF, Steyerberg EW, Ioannidis JP. Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses. BMJ. 2016;355:i5826. https://doi.org/10.1136/bmj.i5826.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work on this project was supported by Grant No. 5R25TW010026-02 from the Fogarty International Center of the U.S. National Institutes of Health.

Author information

Authors and Affiliations

  1. School of Pharmacy, University of Jordan, Amman, 11942, Jordan

    Lobna Gharaibeh

  2. Pharmacy Department, Al-Basheer Government Hospital, Amman, 11151, Jordan

    Hanan Sartawi, Tareq Juma, Diana Ayyad & Samah Sartawi

  3. Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan

    Karem Alzoubi

Authors
  1. Lobna Gharaibeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanan Sartawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karem Alzoubi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tareq Juma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Diana Ayyad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samah Sartawi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lobna Gharaibeh.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gharaibeh, L., Sartawi, H., Alzoubi, K. et al. Patients’ perspectives on participation in clinical trials and subsequent ethical challenges in a hospital setting in Jordan. Int J Clin Pharm 42, 201–208 (2020). https://doi.org/10.1007/s11096-019-00959-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-019-00959-4

Keywords

Search

Navigation